TH89864A - Liquid mixtures - Google Patents
Liquid mixturesInfo
- Publication number
- TH89864A TH89864A TH601003753A TH0601003753A TH89864A TH 89864 A TH89864 A TH 89864A TH 601003753 A TH601003753 A TH 601003753A TH 0601003753 A TH0601003753 A TH 0601003753A TH 89864 A TH89864 A TH 89864A
- Authority
- TH
- Thailand
- Prior art keywords
- sip receptor
- propylene glycol
- drug
- patients
- acceptable
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000012141 concentrate Substances 0.000 claims abstract 5
- 239000003814 drug Substances 0.000 claims abstract 4
- 229940079593 drugs Drugs 0.000 claims abstract 4
- 238000010790 dilution Methods 0.000 claims abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract 3
- 235000011187 glycerol Nutrition 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 239000011780 sodium chloride Substances 0.000 claims abstract 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000000051 modifying Effects 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000018 receptor agonist Substances 0.000 abstract 2
- 229940023488 Pill Drugs 0.000 abstract 1
- 230000004301 light adaptation Effects 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 230000000152 swallowing Effects 0.000 abstract 1
Abstract
DC60 (06/11/49) สารผสมคือสารเข้มข้นสำหรับเจือจางซึ่งประกอบไปด้วยตัวทำการตัวรับ SIP หรือเกลือชนิด ยอมรับได้ของตัวกระทำเหล่านั้น โพรพิลีนไกลคอล และกลีเซอรีนชนิดเลือกได้ สูตรยานี้ได้รับ การปรับใช้สำหรับผู้ป่วยที่กลืนยาเป็นไปด้วยความยากลำบาก สารผสมคือสารเข้มข้นสำหรับเจือจางซึ่งประกอบไปด้วยตัวทำการตัวรับ SIP หรือเกลือชนิด ยอมรับได้ของตัวกระทำเหล่านั้น โพรพิลีนไกลคอล และกลีเซอรีนชนิดเลือกได้ สูตรยานี้ได้รับ การปรับใช้สำหรับผู้ป่วยที่กลืนยาเป็นไปด้วยความยากลำบาก สิทธิบัตรยา DC60 (06/11/49) Mixture is a dilution concentrate consisting of a SIP receptor agonist or a type of salt. Acceptable of those actors Propylene glycol And optional glycerin This drug formula has been Adaptation to patients with difficulty swallowing the drug A mixture is a dilution concentrate consisting of a SIP receptor agonist or a type of salt. Acceptable of those actors Propylene glycol And optional glycerin This drug formula has been The deployment for patients who swallowed the pill was going to be tough.
Claims (3)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH89864A true TH89864A (en) | 2008-05-30 |
| TH89864B TH89864B (en) | 2008-05-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200901277A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DAPAGLYFLOSINE PROPYLENE GLYCOLHYDRATE | |
| WO2006124447A3 (en) | Substituted n-arylpyrrolidines as selective androgen receptor modulators | |
| WO2007087548A3 (en) | Chemical compounds | |
| WO2007002181A3 (en) | Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) | |
| EA200601570A1 (en) | COMPOSITIONS CONTAINING A MOLECULARLY DISPERSED DROSPYRENON | |
| AR045906A1 (en) | PHARMACEUTICAL COMPOSITION TO IMPROVE THE SOLUBILITY OF HYDROPHOBIC PHARMACOS | |
| RU2014115287A (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND METHOD FOR PRODUCING IT | |
| MA28862B1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING AN ACTIVE INGREDIENT | |
| WO2006071564A3 (en) | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents | |
| ATE457721T1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING PHARMACEUTICAL ACTIVE INGREDIENTS ABSORBED ON TITANIUM DIOXIDE DNANOPARTICLES | |
| TH89864A (en) | Liquid mixtures | |
| MX2007015171A (en) | Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant. | |
| TH89864B (en) | Liquid mixtures | |
| WO2008120617A1 (en) | Pharmaceutical composition for prevention of progress of intestinal constriction associated with crohn's disease | |
| WO2008122425A3 (en) | Oral compositions containing tacrolimus in amorphous form | |
| TH95800A (en) | Antibiotics inhibit thrombin by oral administration. | |
| TH136339B (en) | Combination of ferrocin and artemisinin derivatives. For the treatment of malaria | |
| TH91938A (en) | 2--Lcoxin-3,4,5-Trihydroxy-Lkyl Emido-Benzazipine, preparations of these substances, elements containing these substances And the use of these substances | |
| TH89781A (en) | 3- amino-2-alryylpropyl Asaindol and their use | |
| TH104743A (en) | Solid diffusion product containing N-aryl urea compounds. | |
| TH136339A (en) | Ferrocwin aggregates And Artemisinin derivatives For the treatment of malaria | |
| TH95800B (en) | Antibiotics inhibit thrombin by oral administration. | |
| EA200501366A1 (en) | MEDICINE | |
| TH91425A (en) | Formulation | |
| TH134367B (en) | Cyclic protein tyrosine kinase inhibitor |